| Bethann B Powers, CRNA | |
|
303 N Clyde Morris Blvd, Daytona Beach, FL 32114-2709 | |
| (386) 254-4000 | |
| Not Available |
| Full Name | Bethann B Powers |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 42 Years |
| Location | 303 N Clyde Morris Blvd, Daytona Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508845215 | NPI | - | NPPES |
| G2964 | Other | FL | BCBS |
| 302700700 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Halifax Health Medical Center | Daytona beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Clinical Practice Association | 0345146254 | 1636 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | Meese Tolland Ritter & Williams Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578564878 PECOS PAC ID: 1557422078 Enrollment ID: O20090324000522 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | Space Coast Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942441753 PECOS PAC ID: 5496805426 Enrollment ID: O20090611000695 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | Orange City Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972882314 PECOS PAC ID: 2365617016 Enrollment ID: O20111208000641 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | Riverside Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134478209 PECOS PAC ID: 4688824600 Enrollment ID: O20121026000522 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Entity Name | American Anesthesiology Services Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508318387 PECOS PAC ID: 1850674540 Enrollment ID: O20170202001989 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bethann B Powers, CRNA 1329 Sw 16th St Rm 2232, Gainesville, FL 32608-1128 Ph: (352) 733-0485 | Bethann B Powers, CRNA 303 N Clyde Morris Blvd, Daytona Beach, FL 32114-2709 Ph: (386) 254-4000 |
News Archive
A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.
Brittle Type 1 Diabetes (BT1D) is listed by the National Institutes of Health as a rare disease impacting some 4500 people in the USA. It is defined as a severe instability of blood glucose (BG) levels, whatever its cause, with frequent and unpredictable episodes of hypoglycemia (low) and or hyperglycemia (high sugars) that disrupts quality of life.
A group of researchers from the Department of Optics of the University of Granada has studied the effects of smoking cannabis on various visual parameters compared to the effect that the users themselves perceive the drug to have on their vision.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
› Verified 3 days ago